RecruitingNot ApplicableNCT07271030

The Use of Cannabidiol Suppositories for Sexual Pain

The Use of Cannabidiol Suppositories for Sexual Pain: A Randomised Controlled Study


Sponsor

London Metropolitan University

Enrollment

50 participants

Start Date

Jan 16, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Research aim: To determine how cannabidiol suppositories might reduce sexual pain during intimacy. Outcomes are also hoped to increase sexual functioning, well-being, and quality of life. Research intention: If cannabidiol suppository intervention reduces sexual pain and increases general well-being, then this research would be repeated on a larger scale, targeting psychosexual services. A brief overview of the intervention: Quantitatively, randomisation of cannabidiol suppositories will be into dose-specific groups. The intervention will be delivered over a period of one month, with follow-up scheduled at 12 weeks. Qualitatively, participants were asked approximately eight open-ended feedback questions throughout the study.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria9

  • Has previously used cannabidiol in any capacity and has not experienced any allergic reaction
  • Is experiencing sexual pain
  • There will be an absence of co occurring difficulties
  • Has attempted sexual intercourse in the last month
  • Age 18 years or older
  • Read and write English
  • Patient Health Questionnaire 9 screening score range between 0-9 mild
  • General Anxiety Disorder 7 screening score range between 0-9 mild
  • There are no restrictions on sex, gender, sexuality, or disability

Exclusion Criteria7

  • Has experienced an allergic reaction to cannabidiol in any capacity
  • Has not attempted sexual intercourse in the last month
  • Has co occurring difficulties
  • Aged below 18 years old
  • Are not experiencing sexual pain
  • Patient Health Questionnaire 9 screening score range between moderate to severe - 10-27
  • General Anxiety Disorder 7 screening score range between 10- 21.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTCannabidiol suppository intervention 1

Cannabidiol suppository dose specific 30mg

DIETARY_SUPPLEMENTCannabidiol suppository intervention 2

Cannabidiol suppository dose specific 50mg

DIETARY_SUPPLEMENTCannabidiol suppository intervention 3

Cannabidiol suppository dose specific 100mg

OTHERNon cannabidiol group control

Care as usual group


Locations(1)

School of Social Sciences and Professions

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07271030


Related Trials